450 related articles for article (PubMed ID: 32283815)
1. Mesenchymal Stromal Cell Secretome for Severe COVID-19 Infections: Premises for the Therapeutic Use.
Bari E; Ferrarotti I; Saracino L; Perteghella S; Torre ML; Corsico AG
Cells; 2020 Apr; 9(4):. PubMed ID: 32283815
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell (MSc) secretome: A possible therapeutic strategy for intensive-care COVID-19 patients.
Deffune E; Prudenciatti A; Moroz A
Med Hypotheses; 2020 Sep; 142():109769. PubMed ID: 32371362
[TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia.
Akbari A; Rezaie J
Stem Cell Res Ther; 2020 Aug; 11(1):356. PubMed ID: 32795359
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cell-Derived Exosomes Exhibit Promising Potential for Treating SARS-CoV-2-Infected Patients.
Raghav A; Khan ZA; Upadhayay VK; Tripathi P; Gautam KA; Mishra BK; Ahmad J; Jeong GB
Cells; 2021 Mar; 10(3):. PubMed ID: 33799966
[TBL] [Abstract][Full Text] [Related]
5. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
6. Rationale for the Use of Radiation-Activated Mesenchymal Stromal/Stem Cells in Acute Respiratory Distress Syndrome.
Tovar I; Guerrero R; López-Peñalver JJ; Expósito J; Ruiz de Almodóvar JM
Cells; 2020 Sep; 9(9):. PubMed ID: 32887260
[TBL] [Abstract][Full Text] [Related]
7. The use of mesenchymal stromal cells in the treatment of coronavirus disease 2019.
Canham MA; Campbell JDM; Mountford JC
J Transl Med; 2020 Sep; 18(1):359. PubMed ID: 32958009
[TBL] [Abstract][Full Text] [Related]
8. Stem Cells Secretome from Oral Tissue Could Represent a Promising Therapeutic Approach in COVID-19-Disease?
Diomede F; Marconi GD; Fonticoli L; Pizzicannella J; Trubiani O
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957696
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?
Muraca M; Pessina A; Pozzobon M; Dominici M; Galderisi U; Lazzari L; Parolini O; Lucarelli E; Perilongo G; Baraldi E
J Control Release; 2020 Sep; 325():135-140. PubMed ID: 32622963
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.
Gupta A; Kashte S; Gupta M; Rodriguez HC; Gautam SS; Kadam S
Hum Cell; 2020 Oct; 33(4):907-918. PubMed ID: 32780299
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and treatment strategies for COVID-19.
Kumar M; Al Khodor S
J Transl Med; 2020 Sep; 18(1):353. PubMed ID: 32933536
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
Akkoc T
Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
O'Driscoll L
Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
[No Abstract] [Full Text] [Related]
15. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
17. What happens to people's lungs when they get coronavirus disease 2019?
Frizzelli A; Tuttolomondo D; Aiello M; Majori M; Bertorelli G; Chetta A
Acta Biomed; 2020 May; 91(2):146-149. PubMed ID: 32420938
[TBL] [Abstract][Full Text] [Related]
18. The hallmarks of COVID-19 disease.
Tang D; Comish P; Kang R
PLoS Pathog; 2020 May; 16(5):e1008536. PubMed ID: 32442210
[TBL] [Abstract][Full Text] [Related]
19. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
Atluri S; Manchikanti L; Hirsch JA
Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
[TBL] [Abstract][Full Text] [Related]
20. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
